MedPath
NMPA Approval

Roxatidine Acetate Hydrochloride For Injection

国药准字H20249526

December 1, 2024

Drug Information

注射用盐酸罗沙替丁醋酸酯

注射剂

75mg

化学药品

December 1, 2024

Company Information

Applicant Company

海口市海口国家高新技术产业开发区药谷一路4号

Manufacturing Company

海口市海口国家高新技术产业开发区药谷一路4号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸罗沙替丁醋酸酯 - NMPA 批准文号 | MedPath